Alzheimer’s disease (AD), the most common form of dementia, has increasing incidence, increasing mortality rates, and poses a huge burden on healthcare. None of the currently approved drugs for the treatment of AD influence disease progression. Many clinical trials aiming at inhibiting amyloid plaque formation, increasing amyloid beta clearance, or inhibiting neurofibrillary tangle pathology yielded inconclusive results or failed. Meanwhile, research has identified many interlinked vicious cascades implicating oxidative stress, mitochondrial dysfunction, and chronic neuroinflammation, and has pointed to novel therapeutic targets such as improving mitochondrial bioenergetics and quality control, diminishing oxidative stress, or modulating the neuroinflammatory pathways. Many novel molecules tested in vitro or in animal models have proven efficient, but their translation into clinic needs further research regarding appropriate doses, delivery routes, and possible side effects. Cell-based therapies and extracellular vesicle-mediated delivery of messenger RNAs and microRNAs seem also promising strategies allowing to target specific signaling pathways, but need further research regarding the most appropriate harvesting and culture methods as well as control of the possible tumorigenic side effects. The rapidly developing area of nanotechnology could improve drug delivery and also be used in early diagnosis.
Aging is the most prominent risk factor for late-onset Alzheimer’s disease. Aging associates with a chronic inflammatory state both in the periphery and in the central nervous system, the evidence thereof and the mechanisms leading to chronic neuroinflammation being discussed. Nonetheless, neuroinflammation is significantly enhanced by the accumulation of amyloid beta and accelerates the progression of Alzheimer’s disease through various pathways discussed in the present review. Decades of clinical trials targeting the 2 abnormal proteins in Alzheimer’s disease, amyloid beta and tau, led to many failures. As such, targeting neuroinflammation via different strategies could prove a valuable therapeutic strategy, although much research is still needed to identify the appropriate time window. Active research focusing on identifying early biomarkers could help translating these novel strategies from bench to bedside.
Monitoring the indoor microclimate in old buildings of cultural heritage and significance is a practice of great importance because of the importance of their identity for local communities and national consciousness. Most aged heritage buildings, especially those made of wood, develop an indoor microclimate conducive to the development of microorganisms. This study aims to analyze one wooden church dating back to the 1710s in Romania from the microclimatic perspective, i.e., temperature and relative humidity and the fungal load of the air and surfaces. One further aim was to determine if the internal microclimate of the monument is favorable for the health of parishioners and visitors, as well as for the integrity of the church itself. The research methodology involved monitoring of the microclimate for a period of nine weeks (November 2020–January 2021) and evaluating the fungal load in indoor air as well as on the surfaces. The results show a very high contamination of air and surfaces (>2000 CFU/m3). In terms of fungal contamination, Aspergillus spp. (two different species), Alternaria spp., Cladosporium spp., Mucor spp., Penicillium spp. (two different species) and Trichopyton spp. were the genera of fungi identified in the indoor wooden church air and Aspergillus spp., Cladosporium spp., Penicillium spp. (two different species) and Botrytis spp. on the surfaces (church walls and iconostasis). The results obtained reveal that the internal microclimate not only imposes a potential risk factor for the parishioners and visitors, but also for the preservation of the wooden church as a historical monument, which is facing a crisis of biodeterioration of its artwork.
Poor air quality inside museums can have a double effect; on the one hand, influencing the integrity of the exhibits and on the other hand, endangering the health of employees and visitors. Both components can be very sensitive to the influence of the internal microclimate, therefore careful monitoring of the physical parameters and pollutants is required in order to maintain them within strict limits and thus to reduce the hazards that can be induced. The current study considers the determination and analysis of 15 indicators of the internal microclimate in an Art Nouveau museum built at the beginning of the 20th century in the Municipality of Oradea, Romania. The monitoring spanned a period of seven months, between September 2021 and March 2022, targeting three rooms of the museum with different characteristics and containing exhibits with a high degree of fragility. The results show that, although there are numerous indicators that have exceeded the thresholds induced by international standards, the possible negative impact on the exhibits and/or on human health remains moderate. This is due to the fact that, most of the time, exceeding the permitted limits are small or only sporadic, the values quickly returning to the permitted limits. Thus, only 22 of the 212 days of monitoring recorded marginal conditions regarding the quality of the indoor air, the rest having acceptable and good conditions. To improve the indoor conditions, a more careful management is needed, especially regarding the values of temperature, humidity, particulate matters, natural and artificial light, volatile organic compounds (VOC) and formaldehyde (HCHO), which during the measurements recorded high values that fluctuated in a wide spectrum. The obtained results can represent the basis for the development and implementation of long-term strategies for stabilizing the microclimatic conditions in the museum in order to preserve the exhibits preventively and to ensure a clean and safe environment for people.
Stroke is the second cause of disability worldwide as it is expected to increase its incidence and prevalence. Despite efforts to increase the number of patients eligible for recanalization therapies, a significant proportion of stroke survivors remain permanently disabled. This outcome boosted the search for efficient neurorestorative methods. Stem cells act through multiple pathways: cell replacement, the secretion of growth factors, promoting endogenous reparative pathways, angiogenesis, and the modulation of neuroinflammation. Although neural stem cells are difficult to obtain, pose a series of ethical issues, and require intracerebral delivery, mesenchymal stem cells are less immunogenic, are easy to obtain, and can be transplanted via intravenous, intra-arterial, or intranasal routes. Extracellular vesicles and exosomes have similar actions and are easier to obtain, also allowing for engineering to deliver specific molecules or RNAs and to promote the desired effects. Appropriate timing, dosing, and delivery protocols must be established, and the possibility of tumorigenesis must be settled. Nonetheless, stem cell- and cell-based therapies for stroke have already entered clinical trials. Although safe, the evidence for efficacy is less impressive so far. Hopefully, the STEP guidelines and the SPAN program will improve the success rate. As such, stem cell- and cell-based therapy for ischemic stroke holds great promise.
Background and Objectives: Increased and unstructured digital exposure has raised growing concerns about its potential impact on children’s cognitive and behavioral development. Executive functions (EFs)—encompassing attention, working memory, inhibition, and cognitive flexibility—are particularly sensitive to environmental influences during development. Beyond its empirical aim, this study also sought to address a theoretical gap by clarifying how multiple dimensions of digital exposure (quantity, content quality, and sleep-related timing) jointly relate to EF performance, an area insufficiently integrated into current EF frameworks. This study aimed to examine the quantitative and qualitative dimensions of digital exposure in relation to sleep duration and EF performance among Romanian school-aged children and adolescents. Materials and Methods: A cross-sectional study was conducted among 142 students aged 5–19 years, using standardized cognitive tasks and structured parent questionnaires to assess screen time, digital content type, and sleep duration. Analyses included correlational tests, group comparisons, regression models, and moderation procedures. Results: Higher daily screen time was associated with poorer attention and working-memory performance and shorter nocturnal sleep. Children and adolescents who exceeded the recommended daily screen-time limits performed worse on executive-function measures than those within recommended limits. Digital content type and sleep duration each contributed uniquely to executive performance, and recreational digital content as well as younger age intensified the negative effects of screen exposure. Conclusions: Excessive daily screen time, especially involving passive or recreational content, is associated with poorer EF performance and shorter sleep in children. Adequate sleep and educational or interactive digital engagement may mitigate these effects. The findings underscore the importance of age-appropriate, structured, and balanced digital habits to support healthy cognitive development.